Fundraising FoxPresight Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies.
BiotechDeep TechWaltham, US
Errik B. Anderson(Executive Officer, Director)inPiotr Bobrowicz(Executive Officer, Director)inJay Rosanelli(Executive Officer)in
BoardAnthony Sun(Director)Alaa Halawa(Director)Ulrik Nielsen(Director)in
Co-investors82VS8VCAlumni VenturesGermin8 VenturesJIC Venture Growth InvestmentsGaingels+2 more
__Twitter.png)
Peptilogics is a clinical-stage surgical therapeutics company developing zaloganan (PLG0206), a novel anti-biofilm drug to treat and prevent medical device-related infections such as prosthetic joint infections.
BiotechHealthtechMedical DevicesPittsburg, US
Jonathan Steckbeck(Founder)in
BoardStephan Dietrich(Director)in
Co-investorsAAF Management Ltd.Alpha Wave GlobalAMR Action FundBright Success CapitalMountain State CapitalNarya Capital+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.